The report "CRISPR Market by Offering (Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)), Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles - Global Forecast to 2030" The global CRISPR market is anticipated to reach USD 5.47 billion by 2030 from USD 3.21 billion in 2025, at a significant CAGR of 11.2%. The growth of the CRISPR market is driven by several factors. These include the increasing demand for gene and cell therapies, a rise in investments in genomic research, and the expanding applications of CRISPR technology in drug discovery, agriculture, and diagnostics. Additionally, advancements in CRISPR-based tools and delivery systems and a surge in clinical trials for gene editing therapies are further enhancing adoption. Collaborations and partnerships between biotech companies and universities are also fostering supportive government policies and improving access to CRISPR products and services. This combination of factors contributes to the growth of the market in both developed and emerging economies.
Browse 301 market data Tables and 50 Figures spread through 266 Pages and in-depth TOC on "CRISPR Market by Offering (Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)), Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/crispr-technology-market-134401204.html
The services segment is anticipated to grow at a significant CAGR during the forecast period.
The offerings in the CRISPR market are categorized into two segments: products and services. The services segment is further divided into gRNA synthesis & cell line development, screening & validation, and other services. This services segment is experiencing a high CAGR due to the increasing demand for comprehensive and customized gene editing solutions among pharmaceutical companies, biotechnology firms, and research institutions. Additionally, the growing applications in diagnostics and therapeutics and the need for high-throughput and scalable gene editing services are driving rapid growth in this segment.
The CRISPR kits & enzymes segment is anticipated to grow at a significant CAGR during the forecast period.
The CRISPR products market is divided into three categories: CRISPR kits & enzymes, CRISPR libraries, and other products. In 2024, the CRISPR kits & enzymes segment was the largest, primarily due to their wide-ranging applications in various gene editing workflows. This includes processes such as genome modification, gene knockout, and validation studies. CRISPR kits & enzymes are essential reagents for conducting CRISPR experiments and are frequently utilized in bulk by researchers in academia, biotechnology, and the pharmaceutical industry.
The pharmaceutical & biotechnology companies segment is expected to witness the highest growth in the CRISPR services market during the forecast period.
Based on end users, the CRISPR services market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and other end users. Among these, pharmaceutical & biotechnology companies are expected to experience the highest CAGR from 2025 to 2030. This growth is primarily due to their significant investments in drug discovery, gene therapy, and precision medicine. These companies heavily utilize CRISPR-based services, such as cell line engineering, high-throughput screening, and gRNA synthesis, to accelerate their research and development (R&D) processes and facilitate advancements in therapeutic options.
The Asia Pacific region is anticipated to grow at a significant CAGR during the forecast period of 2025–2030.
The CRISPR market is divided by region into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest market share, driven by the presence of numerous top-ranked universities and companies, substantial funding for biotechnology and pharmaceutical research, and a highly developed healthcare system. The Asia Pacific (APAC) region is also experiencing rapid growth due to increasing healthcare demand and expanding research capabilities. Countries like China, India, and Japan are making significant advancements in biotechnology and drug discovery, which is further promoting the use of CRISPR technologies in this region.
The prominent players in the CRISPR market are Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), and GenScript (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/